Warning Letter Wednesday Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
Test ingredients for common adulterants
Takeaway -
Re-review websites if inspected by FDA
Takeaway -
Ensure vendors are properly qualified
Takeaway -
Small labeling issues increase warning letter risk
Takeaway -
Homeopathic products under increased scrutiny
Takeaway -
Re-review online marketing if inspected by FDA
Takeaway -
Test products like glycerin for adulterants
Takeaway -
Formats that are favorable to children should be avoided
Takeaway -
Biomarkers claims elevate enforcement risk
Takeaway -
Kratom companies should be aware
Takeaway -
Product formats & packaging should not appeal to children
Takeaway -
Review videos for compliance concerns